{"id":"NCT02231086","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","briefTitle":"Adjuvant HIPEC in High Risk Colon Cancer","officialTitle":"Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Colon Cancer at High Risk of Peritoneal Carcinomatosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2018-09","completion":"2019-06-01","firstPosted":"2014-09-04","resultsPosted":"2021-09-16","lastUpdate":"2021-09-16"},"enrollment":204,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Colorectal Neoplasms","Peritoneal Neoplasms"],"interventions":[{"type":"PROCEDURE","name":"Adjuvant HIPEC (open/laparoscopic)","otherNames":["I.V. leucovorin 20 mg/m2 (maximum 40 mg)","I.V. 5-fluorouracil 400 mg/m2 (maximum 800 mg)","Intraperitoneal oxaliplatin 460 mg/m2 (maximum 920 mg)"]},{"type":"DRUG","name":"Standard adjuvant systemic chemotherapy","otherNames":["adjuvant capecitabine and oxaliplatin (CAPOX)","adjuvant 5-FU and oxaliplatin (FOLFOX)"]},{"type":"PROCEDURE","name":"Diagnostic laparoscopy","otherNames":["Diagnostic laparoscopic surgery"]}],"arms":[{"label":"Standard adjuvant systemic chemotherapy","type":"ACTIVE_COMPARATOR"},{"label":"Adjuvant HIPEC (open/laparoscopic)","type":"EXPERIMENTAL"}],"summary":"This study aims to determine the oncological effectiveness of adjuvant HIPEC, using intraperitoneal oxaliplatin with concomitant i.v. 5-FU/LV, following a curative resection of a T4 or intra-abdominally perforated Colon cancer in preventing the development of peritoneal carcinomatosis in addition to the standard adjuvant systemic treatment.\n\nHypothesis:\n\nThe hypothesis is that adjuvant HIPEC preceding routine adjuvant systemic therapy using i.p. oxaliplatin with concomitant i.v. 5-FU/LV following a curative resection of a T4 or intra-abdominally perforated colon cancer reduces the development of peritoneal carcinomatosis in comparison to standard adjuvant systemic treatment alone.","primaryOutcome":{"measure":"Peritoneal Recurrence Free Survival at 18 Months","timeFrame":"18 months","effectByArm":[{"arm":"Standard Adjuvant Systemic Chemotherapy","deltaMin":79,"sd":null},{"arm":"Adjuvant HIPEC (Open/Laparoscopic)","deltaMin":80,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":14},"locations":{"siteCount":9,"countries":["Netherlands"]},"refs":{"pmids":["40374989","37922442","36123540","31371228","26003804"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":102},"commonTop":["diarrhea","peripheral sensible neuropathy","fatigue","vomiting","mucositis"]}}